Open Access · CC BY 4.0
Correction to “Nanobiotechnology‐mediated radioimmunotherapy treatment for triple‐negative breast cancer”
MedComm – Biomaterials and Applications · 2026-12 · 5 (4)
DOI: 10.1002/mba2.70098 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedComm – Biomaterials and Applications, online erschienen am 03.11.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to “Nanobiotechnology‐mediated radioimmunotherapy treatment for triple‐negative breast cancer”. MedComm – Biomaterials and Applications, 5(4). https://doi.org/10.1002/mba2.70098
Vancouver
Correction to “Nanobiotechnology‐mediated radioimmunotherapy treatment for triple‐negative breast cancer”. MedComm – Biomaterials and Applications. 2026;5(4). doi:10.1002/mba2.70098
BibTeX
@article{euvimed2026,
title = {Correction to “Nanobiotechnology‐mediated radioimmunotherapy treatment for triple‐negative breast cancer”},
journal = {MedComm – Biomaterials and Applications},
year = {2026},
volume = {5},
number = {4},
doi = {10.1002/mba2.70098}
}
EUVIMED